Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data. - Epstein S; Xia Z; Lee AJ; Dahl M; Edwards K; Levit E; Longbrake EE; Perrone C; Kavak K; Weinstock-Guttman B; Diallo F; Ricci A; et al. (Multiple sclerosis and related disorders, 2022)